Search

everythinglearnresearchcommunity

for

Search:↓

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Six new risk spots for early hair loss were found, which also link to Parkinson's disease and lower fertility. Two genes, FOXA2 and HDAC4, could be new treatment targets. Hair loss might also be connected to heart disease, metabolic syndrome, and prostate cancer.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

The book "Hair Science and Technology" provides a deep understanding of hair biology and genetics, discusses hair growth, density, and diseases, and offers methods for managing hair loss and caring for hair growth.

The paper concludes that breast cancer treatment involves complex interactions between medical symptoms, patient experiences, and commercial influences, requiring a holistic approach.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.

Scube3 gene affects mouse embryo growth in multiple areas, but needs more research.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

The meeting concluded with optimism about increasing research and better management of vitiligo.

The botanical treatment for hair loss shows promise, especially for children.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

New skin substitutes for treating severe burns and chronic wounds are being developed, but a permanent solution for deep wounds is not yet available commercially.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Cinnamon essential oil can cause severe or unusual skin reactions, with cinnamaldehyde being the main allergen.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Some antidepressants can cause emotional numbness and other unusual side effects.

Keratin films from human hair can potentially replace human nail plates for drug testing.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Optimized film improves finasteride skin absorption and treatment efficiency.

Hair analysis for drugs in psychosis patients is unreliable due to varying hair growth rates.